In the most critically ill patients on ECMO support, we observed a drop in catecholamine demand and an improvement in clinical state on ECMO.
In my experience the vasopressor doses decreased, biomarkers of sepsis (…) and the inflammatory response as well as multiple organ function improved.
Listen to Dr. Heinz Jakob talk about his experiences with CytoSorb Therapy.